Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Novartis is expected to select Merkley Newman Harty & Partners here to handle creative duties on prescription skin medication Elidel after a roster shop shootout, sources said. Billings are estimated at $50 million.
The other finalists were Interpublic Group’s Deutsch in New York and incumbent The Quantum Group in Parsippany, N.J., which is a division of WPP Group’s CommonHealth, said sources. The agencies declined comment and the East Hanover, N.J.-based client could not immediately be reached.
Merkley,
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in